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Abstract
Background: Low birth weight (BW), small head circumference, reduced length, increased preterm
births and neuro-endocrine dysfunctions are among known consequences of smoking during
pregnancy. Few studies have linked leptin to clinical features of growth restriction associated with
maternal smoking and explored interaction with other determinants of size at birth, such as gender.
Methods: Cord serum leptin concentrations were measured in 1215 term infants born to Caucasian
mothers at completion of uneventful pregnancy. Serum concentrations were related to BW, gestational
length, gender and maternal smoking and interaction with other determinants of size at birth
evaluated.
Results: Smoking was more frequent inyounger(P!0.001) and shorter mothers (PZ0.03) from lower
socio-economic groups (SEGPs) (P!0.001). Infants born to smokers were lighter (190 g less), shorter
and with smaller head circumference. Cord serum leptin concentrations were higher in girls (9.8 S.D.
7.6 ng/ml) than in boys (7.05 S.D. 5.8 ng/ml) (P!0.001). Boys were heavier (BW 3.52 S.D. 0.49 kg)
than girls (3.39 S.D. 0.44 kg) (P!0.001), but girls had greater skinfold thickness measurements (sub-
scapular and quadriceps skinfold thicknesses 5.5 S.D. 1.6 mm and 7.6 S.D. 1.9 mm respectively; boys
5.3 S.D. 1.6 vs 7.24G1.90 mm, P!0.001 respectively). Multivariate analyses showed gender
(P!0.001), BW SDS (P!0.001), gestational length (P!0.001) and maternal smoking (P!0.042) as
factors that inﬂuenced umbilical cord serum leptin concentrations in newborns.
Conclusion: Maternal smoking restrains foetal growth through placental vascular effects, andlikelyalso
via associated effects on leptin metabolism. More studies are needed to determine the inﬂuence that
maternal smoking may have on placental syncytiotrophoblast and foetal adipose tissue.
European Journal of Endocrinology 159 217–224
Introduction
In 1957, Simpson described the association of maternal
smoking with foetal growth restraint (1). Since then a
series of studies have demonstrated a consistent effect of
maternal smoking on foetal growth with reductions in
birth weight (BW), length and head circumference.
Moderate-to-heavy maternal smoking is responsible for
an average reduction in BW of 90–200 g in infants
whose mothers smoked during pregnancy (2). Foetal
growth restriction is an important determinant of
perinatal morbidity and mortality; and in the longer
term, epidemiological studies suggest that intrauterine
growth restriction predisposes to the development of the
metabolic syndrome (the association of obesity, arterial
hypertension, hyperlipidaemia, cardiovascular disease,
impaired glucose tolerance and insulin resistance) (3).
Smoking during pregnancy has also been implicated
in neurological endocrine as well as maturational
modiﬁcations observed in infants born to smoking
mothers (4).
The impact of maternal smoking on foetal growth
arises in a number of ways either directly by reducing
foetal growth as environmental toxin, by shortening
gestational length (1, 5, 6), thus increasing the
incidence of premature births, or by altering utero-
placental and foetal blood ﬂow, with consequent
decrease in oxygen consumption, nutritional and
energy supply to the foetus (7, 8). The classic measures
of foetal growth, e.g. BW, are composites of a number of
components each inﬂuenced to varying degrees by a
series of growth factors. Longitudinal growth in utero is
insulin-like growth factor-I (IGF-I) dependent and
circulating concentrations of IGF-I are reduced in
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pregnancy (9). Other factors inﬂuence the development
of adipose tissue, which is an important component of
weight in the last 8 weeks of pregnancy.
Leptin, a 167 amino acid protein from the obese gene,
is synthesized mostly in white adipose tissue but also in
the placenta, and as a regulatory molecule of appetite it
circulates at a concentration that is proportional to fat
mass in both humans and rodents (10). A positive
correlation between its cord concentrations, body
weight and fat mass has been found in newborn infants
(11), suggesting that leptin may play a role in the
regulation of foetal adiposity.
The interaction of leptin with factors inﬂuencing
foetal growth has not been determined and conﬂicting
reports have been published on the impact of maternal
smoking on cord serum leptin concentrations (12–15).
In this report, we describe cord serum leptin concen-
trations in 1215 newborn infants born at term to
Caucasian mothers and relate leptin values to BW,
gestational age, gender and maternal smoking during
pregnancy. Our aim was to answer the question of
whether smoking during pregnancy, in addition to
known mechanisms, also restricts foetal growth via its
action on leptin metabolism.
Subjects and methods
Study group
Thestudycohortandourinclusionandexclusioncriteria
havebeendescribedelsewhere(9). Thepresentstudywas
conﬁned to term-born infants (gestational age O37
weeks; gestational age was determined according to last
menstrual date and/or the ﬁrst obstetrical ultrasound).
Maternal cigarette smoking was categorized as: never
smoked (group 1, nZ870), stopped on becoming
pregnant (group 2, nZ117), smoked less than 10
cigarettes/day (group 3, nZ115), smoked 10–20
cigarettes/day (group 4, nZ90) and smoked more than
20 cigarettes/day (group 5, nZ26). Socio-economic
status was determined from age at which full-time
education was completed, marital status, occupation and
partner’s occupation, and social class assignment was
made using the classiﬁcation of the United Kingdom
Ofﬁce of Population Census and Statistics (Standard
Occupational Classiﬁcation Volume 3. OPCS 1991).
Pregnancy complications were noted and infants
excluded from analysis from those mothers who
developed complications of pregnancy.
Complete perinatal outcome and anthropometric
data (BW, length, head and mid-arm circumference)
were available in 1484 babies. BW was measured
using self-calibrating electronic scales (Seca,
Birmingham, UK), length was measured using Infanto-
meter (Child Growth Foundation, London, UK) and
head circumference with a metal tape (Holtain,
Crymych, UK). Ponderal index was calculated as
weight/length
3 and skinfolds (triceps, sub-scapular
and quadriceps) were measured using skinfold callipers
(Holtain); three separate measurements were taken and
the mean recorded. The coefﬁcient of variation of the
measurement error for length was 0.15% based on ten
infants, each having been measured ﬁve times by three
observers. Blood sample was collected after birth and
before completion of the third stage of labour into EDTA
from the umbilical vein. The sample was centrifuged,
after cord blood pH was measured, separated and
plasma stored immediately at K20 8C until leptin
assays were performed within 3 months of collection.
The study received approval from the Research Ethics
Committee of University College London Hospitals, and
written informed consent for participation obtained
from the mothers both for own participation and that of
their newborn child after its birth.
Leptin assay
Serum leptin concentration was measured by commer-
cial RIA (Linco Research Inc., St Charles, MO, USA). The
within-assay coefﬁcients of variation (CV) were 8.3, 3.9
and 3.4 at 4.9, 10.4 and 25.6 ng/ml respectively. The
between-assay CV values were 5.6 and 6.3 at 3.5 and
15.5 ng/ml respectively. The calibrants in the assay
were from puriﬁed recombinant human leptin. The
minimum detection limit was 0.5 ng/ml.
Statistical analysis
Anthropometric measures (BW, length and head
circumference) were expressed as SDS using the 1990
British growth reference (16). Correlations between
hormonal data and anthropometrics measures were
estimated usingPearson’scorrelation coefﬁcient. c
2 was
used to compare the distribution of frequencies between
groups. One-way ANOVA was used to determine
differences between the mean values of the groups with
Student–Newman–Keuls post hoc test to determine
signiﬁcance between groups. Multiple linear regression
analysis was used to explore the effects of maternal
smoking, infant’s gender (male 1, female 2), BW (SDS),
placental weight and gestational length on cord serum
leptin concentration.
Results
General
In the study, 1650 mothers were enrolled and 1484 live
infants were delivered, of whom 70 were preterm
infants. Of the remaining 166 who did not deliver,
127 did not complete the study either because they had
moved away or because they were lost to follow-up,
28 patients pregnancies were terminated either into
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withdrew from the study. Analysis is therefore conﬁned
to 1215 term infants (gestational age O37 weeks) born
to mothers whose pregnancies were uncomplicated by
gestational diabetes, utero-placental hypoxia–ischae-
mia–antepartum haemorrhage, pregnancy-induced
hypertension and pre-eclampsia. Clinical and anthro-
pometric characteristics of mothers enrolled for this
studyare summarized in Table 1 and showthat mothers
who smoked heavily were younger (one-way ANOVA
FZ27.4; P!0.001) and shorter (FZ2.64; PZ0.003)
and from SEGPs 4 and 5 (SEGP 1, 96% non-smokers
versus 56% in SEGP 5; P!0.001). Maternal body mass
index was not signiﬁcantly different between smokers
and non-smokers. Smoking habit was not inﬂuenced by
parity. No signiﬁcant differences were found between
groups with regard to maternal pre-gestation weight,
weight gain during pregnancy (data not shown),
gestation at ﬁrst antenatal attendance, gestational age
at delivery and blood pressure at ﬁrst antenatal
attendance or maternal haemoglobin.
Size at birth Neonatal anthropometric measures are
summarized in Table 2. Overall, there were signiﬁcant
sex differences in BW, length and head circumference,
with male infants being heavier, longer and leaner, and
having larger heads than females. Infants born to
mothers who smoked showed BW (a reduction of
190 g), length and head circumference that were
lower, compared with those of infants of non-smoking
mothers (P!0.05 for groups 1 and 2 versus groups
3–5); differences between groups (smoking and non-
smoking) in these three parameters were not dose
dependent.
Although no statistically signiﬁcant differences could
be observed between infants of smokers and those of
non-smokers in skinfold thickness and mid-arm
circumference, male infants had greater mid-arm
circumference but smaller skinfolds than females. Fine
analysis and comparison of BW between infants born to
smoking mothers and those of non-smokers showed
that frequency of babies with BW (SDS) below the third
centile did not differ (4.8% vs 2.8%; c
2 6.37; PZ0.17)
between the two groups. There were, however, more
babies with BW comprised between the third and the
tenth centile born to smoking mothers when compared
with non-smokers (19% vs 7%; c
2 33.2; P!0.001).
Cord serum leptin concentration Table 3 compares
cord serum leptin concentration, BW, ponderal index,
triceps, sub-scapular and quadriceps skinfold thick-
nesses between sexes. Cord serum leptin concentrations
were higher in girls than boys (P!0.001); although the
latter had higher BWs, girls had higher skinfold
thickness measurements.
The effects of maternal smoking on cord serum leptin
concentrations are shown in Fig. 1. There was no
signiﬁcant difference between the groups. The P value
for comparison of cord leptin concentrations in non-
s m o k e r sw i t ht h eo t h e rg r o u p si ss u m m a r i z e di n
Table 4. Multiple regression analyses were then
performed with umbilical cord serum leptin concen-
tration as dependent variable, and infant’s gender, BW
(SDS), gestational length and maternal smoking during
pregnancy as independent variables. BW (P!0.001),
gender (P!0.001), gestational length and maternal
smoking were of signiﬁcant importance. Multivariate
analyses with maternal smoking, placental weight,
gender, gestational length and BW (SDS) showed that
gender (P!0.001), BW SDS (P!0.001), gestational
length (P!0.001) and maternal smoking (P!0.042)
were the important factors that were associated with
umbilical cord serum leptin concentration in newborns.
Discussion
This study was designed to assess the effects of maternal
smoking during pregnancy on foetal cord serum leptin
concentration at birth, in term infants, and hence
answer the question of whether foetal growth restric-
tion secondary to maternal smoking during gestation
could result from the action of the latter on foetal leptin
metabolism (Table 5).
Our results show effectively that factors associated
with cord serum leptin concentrations in newborns are
gender, gestational age, as well as smoking during
pregnancy.Inaccuracyofself-reportedsmokinghabitsin
comparison with cotinine assay byour study population
is a likely criticism that may be made of this study.
Biologicalassays,althoughmoreaccurate,oftenprovide
Table 1 Clinical and anthropometric details of mothers enrolled in the study.
Non-smokers
(nZ868)
Stopped
(nZ117)
!10/day
(nZ114)
10–20/day
(nZ90)
O20/day
(nZ26)
Age (years) 31.8 (5.3) 31.2 (5.1) 27.6 (5.7) 27.9 (5.8) 27.5 (5.3)
Height (cm) 164.8 (6.9) 165.2 (6.6) 163.9 (6.5) 162.9 (6.0) 162.5 (6.6)
Weight (kg) 63.8 (11.1) 64.1 (9.2) 63.2 (10.4) 62.2 (11.8) 65.8 (17.7)
BMI (kg/m
2) 23.6 (4.2) 23.6 (3.9) 23.2 (3.4) 23.4 (4.3) 24.7 (6.0)
Gestation at delivery (weeks) 39.7 (1.3) 40.0 (1.3) 39.6 (1.4) 39.7 (1.2) 39.5 (1.4)
Data shown as mean with S.D. in parenthesis.
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exposure. Moreover, some studies have reported good
correlation between self-reporting versus cotinine assay
and smoking effects on foetal growth (17, 18).
Leptin and gender
The gender difference in serum leptin concentrations
previously reported by several other studies (13, 14, 17)
was also found in our study. Cord serum leptin
concentrations were higher in girls than boys. It is
tempting to speculate that, boys being heavier than
girls, their body weight likely reﬂects heavier muscle
bulk and skeleton, whereas higher leptin concentrations
in girls are correlated with more subcutaneous fat. As
this gender difference in body fat distribution is present
as early as during antenatal life, we consider, like Jaquet
et al. (19) that body weight at birth does not reﬂect body
fat mass alone.
There are several explanations to the gender
difference in cord serum leptin concentrations: for
Tome et al. (20), the sex-based differences are not
attributable to any growth-related differences between
boys and girls, but may simply reﬂect a sex-based
difference in the regional adipose tissue regulation of
leptin production. For Bennet et al. (21), however,
sexual dimorphism is probably the result of regional
distribution of adipose tissue. Van Harmelen et al. (22)
suggested that gender difference in leptin concentration
was a consequence of variation in leptin secretion
present in women and not in men. Like Nagy et al. (23),
we think that the sexual dimorphism in cord serum
leptin concentration is likely to be due to both relative
body composition and fat distribution, which are
different in male and female infants. The gender
differences in cord leptin concentrations reported here
are, however, not a constant ﬁnding in the literature,
some studies have reported similar concentrations in
boys and girls (13). The reasons for these discrepancies
are yet to be elucidated.
Effects of maternal smoking on placental
circulation and foetal growth
Effects of maternal smoking on placental morpho-
logy and function Active maternal smoking during
gestation induces morphological changes with conse-
quent reduction in both volume of maternal intervillous
space and surface area of foetal capillaries (24), these
changes lead to reduced oxygen diffusion across the
placenta. Metabolites of cigarette smoke cross the
placenta, passing from mother to foetus, and act as
vasoconstrictors that reduce uterine blood ﬂow by up to
38% (25). Of note is the fact that smoking hypoxia is not
exclusively pre-placental in origin, but is complicated by
both blood ﬂow problems and cadmium toxicity that act
at trophoblastic as well as other placental sites (26).
Maternal smoking, therefore, places the foetus under
chronic hypoxic stress, and hence contributes to
restriction in weight gain, reduced length and small
head circumference. Based on the model classifying the
origins of hypoxiaby Kingdom et al. (26), three principal
classes are recognized: pre-placental, utero-placental
Table 2 Newborn infants’ anthropometric measures in relation to maternal smoking status.
Non-smokers
(nZ868)
Stopped
(nZ117)
!10/day
(nZ114)
10–20/day
(nZ90)
O20/day
(nZ26) P
BW 0.18 (0.96) 0.04 (0.87) K0.28 (0.99) K0.23 (0.95) K0.29 (1.25) !0.001
BL K0.08 (1.11) 0.03 (1.24) K0.33 (1.23) K0.48 (1.16) K0.61 (1.16) 0.001
HC 0.01 (1.10) 0.04 (1.10) K0.38 (1.10) K0.33 (1.02) K0.29 (1.37) 0.001
TS 5.8 (1.5) 6.2 (1.7) 5.7 (1.6) 5.8 (1.6) 5.8 (1.8) 0.06
SS 5.4 (1.6) 5.5 (1.4) 5.2 (1.7) 5.3 (1.5) 5.5 (2.2) 0.62
QS 7.5 (1.9) 7.6 (1.8) 7.2 (2.1) 7.3 (2.0) 7.1 (2.3) 0.47
MC 10.6 (1.0) 10.6 (1.0) 10.3 (1.0) 10.4 (1.0) 10.5 (1.3) 0.11
Data are presented as mean with S.D. in parentheses, skinfold thicknesses expressed in mm. BW, birth weight; BL, birth length; HC, head circumference; TS,
triceps skinfold; SS, sub-scapular skinfold; QS, quadriceps skinfold; MC, mid-arm circumference.
Table 3 Comparisons between boys and girls of anthropometric measures and cord serum leptin concentrations.
Sex BW (SDS) PondInd. Triceps SF SSSF Quad SF Cord leptin
Male 3.52 (0.49)
(nZ632)
27.34 (3.25)
(nZ613)
5.77 (1.60)
(nZ577)
5.28 (1.54)
(nZ576)
7.24 (1.90)
(nZ573)
7.05 (5.84)
(nZ474)
Female 3.39 (0.44)
(nZ586)
27.57 (3.14)
(nZ575)
5.86 (1.50)
(nZ527)
5.48 (1.60)
(nZ527)
7.62 (1.87)
(nZ521)
9.77 (7.60)
(nZ442)
P value !0.001 0.236 0.348 0.032 0.001 !0.001
BW, birth weight; PondInd, ponderal index; Triceps SF, triceps skinfold thickness; SSSF, sub-scapular skinfold thickness; Quad SF, quadriceps skinfold
thickness. Skinfold thickness in mm and cord leptin in ng/ml. Data shown as mean with S.D. in parentheses.
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normally lead to the pre-placental type of this classi-
ﬁcation, in which there is reduced oxygen content in
maternal blood. The study by Bush et al. (27) has,
however, reported elevated maternal and foetal haema-
tocrit levels in the smokinggroup,in addition to reduced
mean BW in children. Within the placentas, these
authors found increases in cadmium levels, in the
relative volumes of maternal intervillous space and in
the relative surface areas of foetal capillaries, and
decreases in the relative and absolute volumes of foetal
capillaries. These ﬁndings suggest that foetuses of
smoking mothers are under hypoxic stress that could
be, in part, due to the non-adaptative morphological
changes found in the placenta. Smoking-induced
hypoxia could, therefore, be both pre-placental and
utero-placental.
Maternal smoking and foetal growth Effects of
maternal smoking on foetal growth have been exten-
sively studied (1, 6, 9, 28), low BW in children of
smoking mothers is well documented, and our results
conﬁrm those of previous studies, with infants born to
smoking mothers being 190 g lighter than those of non-
smoking ones. Our results are, in this respect, similar to
those reported by Habeck et al. (28), with infants born to
heavy smokers being the most growth restricted.
Physio-pathological mechanisms underlying the effects
of smoking during pregnancy on foetal growth are,
however, only partially elucidated: impairment of
foetal growth has been reported to result from altered
utero-placental and foetal blood ﬂow, and IGF-I axis as
demonstrated in our previous study (9). Intrauterine
growth restricted infants have recently been shown to
have impaired growths of internal organ (small kidneys,
liver and lungs), and it has been suggested that this
could contribute to the occurrence of metabolic
dysfunction in these children later in life (29).
Bouhours-Nouet et al. have shown that smoking in
pregnancy depletes placental mitochondria and induces
respiratory chain complex III deﬁciency. Conjunction of
these effects, likely, contributes to foetal growth
restriction by limiting cellular energy availability to
the foetus (30). In another study, Agostini et al.h a v e
reported that maternal smoking could also affect foetal
growth by reducing docohexaenoic acid synthesis and/
or its maternal transfer to the foetus (31). With regard
to compartments that contribute to the reduction in
foetal size, contradictory research has been reported:
total body electrical conductivity analyses and some
anthropometric measurement studies have shown that
growth restriction is predominant in the lean body
tissues, with no changes in s.c. fat stores (32). Other
studies have, however, suggested that generalized
reduction in neonatal size affects proportionately fat
and lean body masses (33). In a study of term-born
appropriate for gestational age (AGA) infants, Clapp
et al. (11) found fat mass to be the major morphometric
determinant of cord leptin concentration. These authors
also suggested that strong relationship existing between
neonatal fat mass and BW on one side and weak
relationship between it and neonatal fat-free mass on
the other side were due to the large contribution made
by fat mass to the variability inBW. In support to Clapp’s
ﬁndings is the fact that cord leptin concentrations are
lower in small for gestational age (SGA) and preterm
infants, known to have much less fat, in comparison
with AGA and term-born infants (12). Regardless of
conﬂicting reports on the body compartment that is
most affected in growth restriction, it is likely that
impairment in s.c. fat deposition is the major con-
tributor to reduced foetal weight gain (34).
Effects of maternal smoking on cord serum
leptin concentrations
Leptin is produced in the human placenta and secreted
into both maternal and foetal circulations (35). The
exact proportion of cord leptin that originates from
foetal adipose tissue in comparison with that from
placental production remains unknown. Estimations of
placental leptin that is released into foetal circulation
vary from 1.5 to 13.6% (36), the remaining proportion
derives directly from foetal adipose tissue. During
normal pregnancy, leptin has been shown to rise
considerably in maternal circulation, followed by a
rapid fall after parturition (35). Smoking probably
inﬂuences both placental and foetal adipose tissue
leptin production, although on a cord blood sample it
Figure 1 Cord leptin concentrations (ng/ml) according to maternal
smoking status. 1, never smoked; 2, stopped smoking; 3, smoked
!10 cigarettes; 4, smoked 10–20 cigarettes; 5, smoked O20
cigarettes/day.
Table 4 Cord leptin concentrations in relation to maternal smoking
or non-smoking status.
Smoking status N
Mean cord
leptin (S.D.) P value
Never smoked 657 8.53 (6.90)
Stopped smoking 85 7.63 (5.43) 0.79
Smoked !10 cigarettes 82 8.03 (7.20) 0.97
10–20 cigarettes 74 7.60 (6.26) 0.81
O20 cigarette 18 10.63 (11.72) 0.70
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is needed to clarify this.
Several studies have analysed the effects of maternal
smoking on cord serum leptin concentration, with
discordant results (11–14). In the study by Helland et al.
(13), children of smoking mothers were lighter than
those of non-smokers, plasma leptin concentrations
were, however, similar between the two groups. For
these authors, reduced BW in neonates of smoking
women is not consequent to altered leptin concen-
tration. Pardo et al. (12) also studied the effect of
maternal smoking on leptin concentrations in term
appropriate-for-gestational-age newborns, and reported
similar leptin concentrations between infants of smok-
ing and those of non-smoking mothers. Mantzoros et al.
(11) have, however, reported that maternal smoking
during pregnancy was associated with decreased cord
leptin concentrations of both full-term and preterm
newborns. For these authors, smoking during preg-
nancy induces reduction in foetal cord serum leptin
concentration through depletion of foetal energy stores
directly via substances present in tobacco smoke or
indirectly by compromising nutrient supply consequent
to induced placental changes. Another pathway
through which smoking could inﬂuence leptin concen-
trations in neonates may be through decreased energy
stores in foetal adipose tissue, probably via an increase
in foetal catecholamine level. The later phenomenon is
known to increase lipolysis. In another recent study by
Ozkan et al. (14), maternal smoking has been shown to
lower foetal plasma leptin concentration independently
of BW. In our study, although comparison of cord serum
leptin concentrations between infants born to smokers
and those of non-smokers did not reach statistical
signiﬁcance (univariate analysis), multiple regression
analysis performed with cord serum leptin concen-
tration as dependent variable tends to suggest that
infant’s gender, BW, gestational length and maternal
smoking during gestation were the more signiﬁcant
independent variables that inﬂuenced cord serum leptin
concentrations. We have shown that BW SDS is
signiﬁcantly different between infants of smokers when
compared with those of non-smokers; we could not,
however, ﬁnd statistically signiﬁcant difference in cord
serum leptin concentrations between the two groups
(smokers versus non-smokers). Infants born to heavy
smokers (O20 cigarettes/day) had cord serum leptin
concentrations that were slightly higher; the reason for
this discrepancy remains unexplained. The likely, but
speculative explanations could be that these infants
whowere also the smallest (severe SGA), could have had
enhanced endogenous steroidogenesis (secondary to
chronic hypoxia) leading to an increase in leptin
synthesis (37). Whether maternal smoking also
restrains foetal growth by altering foetal leptin metab-
olism is not established with certainty, but this
hypothesis cannot totally be ruled out.
Smoking during pregnancy deprives the foetus of
nutrients and oxygen, resulting in episodic foetal
hypoxia–ischemia and malnutrition. Smoking-
induced foetal stress has been shown to be associated
with raised amniotic ﬂuid catecholamine concen-
trations, but studies have reported conﬂicting results
in this regard, with some reporting increased amniotic
levels (38) and others reporting lower cord catechol-
amine concentrations (39). That cigarette smoking
during pregnancy could also impair foetal growth via
leptin metabolism seems feasible, this would probably
result from increased foetal lipolysis secondary to
raised catecholamine concentrations. Systemic
nicotine treatment in healthy men has, indeed, been
shown to stimulate human adipose tissue lipolysis
through local cholinergic and catecholaminergic
receptors (40).
Table 5 Placental weight and mother’s body mass index (BMI) according to smoking status.
N Mean S.D. Std. error
95% Conﬁdence interval
for mean
Minimum Maximum
Smoking
status Lower bound Upper bound Lower bound Upper bound Lower bound Upper bound Lower bound Upper bound
placwt
1 778 673.23 129.240 4.633 664.13 682.32 320 1240
2 99 668.37 135.743 13.643 641.30 695.45 400 1100
3 89 667.03 120.568 12.780 641.64 692.43 400 990
4 79 669.94 115.821 13.031 643.99 695.88 380 1000
5 24 667.71 169.090 34.515 596.31 739.11 410 1160
Total 1069 671.90 129.000 3.945 664.15 679.64 320 1240
BMI
1 803 23.599 4.2150 0.1487 23.307 23.891 16.0 52.6
2 113 23.620 3.8848 0.3654 22.896 24.344 18.2 45.7
3 104 23.167 3.3893 0.3323 22.508 23.826 16.7 34.3
4 84 23.371 4.2493 0.4636 22.449 24.294 18.0 44.8
5 25 24.710 5.9604 1.1921 22.250 27.170 17.7 40.4
Total 1129 23.569 4.1607 0.1238 23.326 23.812 16.0 52.6
1, never smoked; 2, stopped smoking; 3, smoked !10 cigarettes/day; 4, smoked 10–20 cigarettes/days; 5, smoked O20 cigarettes/day.
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to foetal growth restriction, therefore, implies multi-
factorial physio-pathological mechanisms, some of
which have been elucidated (IGF-I, placental changes,
blood ﬂow effects, etc). Nicotine-induced hypoxia has
been extensively studied, cadmium toxicity acts at
trophoblastic as well as other placental sites (26) and
leptin is produced in large amounts by the syncytio-
trophoblast (36); whether nicotine and/or cadmium
toxicity impairs the expression of leptin mRNA here,
needs to be studied further.
Conclusion
We have shown that maternal smoking during
pregnancy restrains foetal growth, with infants born
to heavy smoking mothers being the smallest. Our study
also conﬁrms the gender difference in cord serum leptin
concentrations between boys and girls. Cord serum
leptin concentrations, although slightly elevated in
infants of heavy smokers, could not reach the level of
signiﬁcance. Multivariate analysis, however, points out
gender, BW, gestational length and maternal smoking
as most signiﬁcant independent variables that inﬂuence
cord leptin concentrations. We, therefore, think that
maternal smoking also likely impairs foetal growth via
its effects on leptin metabolism, in addition to well-
known placental vascular effects. Studies are awaited to
analyse the effects of maternal smoking on both
placental syncytiotrophoblast and foetal adipose tissue.
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